Arbeit Robert D. 4
4 · IDERA PHARMACEUTICALS, INC. · Filed May 24, 2013
Insider Transaction Report
Form 4
Arbeit Robert D.
VP Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2013-05-22+217,750→ 217,750 totalExercise: $0.69Exp: 2023-05-22→ Common Stock (217,750 underlying)
Footnotes (1)
- [F1]The option vests with respect to 40% of the underlying shares on the first anniversary of the date of grant and with respect to 20% of the underlying shares on each of the second, third and fourth anniversaries of the date of grant.